Anna Kawashiri Shun-Ichiro Nakagawa Chisato Ishiguro Kanako Mochizuki Yoshinobu Maeda Toshiro Kurokawa
10.3960/jslrt.22014
J Clin Exp Hematop
2022;62(3):175-180.
chronic gvhd haploidentical stem cell transplantation post-transplantation lymphoproliferative disorder (ptld)
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/36171097/
Epstein-Barr Virus Infections Graft vs Host Disease / etiology Graft vs Host Disease / prevention & control Hematopoietic Stem Cell Transplantation / methods Leukemia, Myeloid, Acute / genetics Leukemia, Myeloid, Acute / therapy Lymphoma, Large B-Cell, Diffuse / drug therapy
Epstein-Barr Virus Infections Graft vs Host Disease / etiology Graft vs Host Disease / prevention & control Hematopoietic Stem Cell Transplantation / methods Leukemia, Myeloid, Acute / genetics Leukemia, Myeloid, Acute / therapy Lymphoma, Large B-Cell, Diffuse / drug therapy Case Reports Antilymphocyte Serum / therapeutic use Azacitidine / therapeutic use Busulfan / therapeutic use HLA Antigens Herpesvirus 4, Human Humans In Situ Hybridization, Fluorescence Male Melphalan / therapeutic use Methotrexate / therapeutic use Middle Aged Positron Emission Tomography Computed Tomography Tacrolimus / therapeutic use Transplantation Conditioning / methods Antilymphocyte Serum HLA Antigens Busulfan Azacitidine Melphalan Tacrolimus Methotrexate
PMC9635034
36171097
Donor-derived diffuse large B-cell lymphoma after haploidentical stem cell transplantation for acute myeloid leukemia
2022